Aims and objectives
are responsible for the reduced quality of life in terms of pain,
loss of mobility and independence,
and disability . Many disorders affect the hip joint such as rheumatoid arthritis,femoral-acetabular impingement but osteoarthritis (OA) is certainly the most frequent pathology of the hip joint,
particularly in population over 45 years old with a prevalence ranging from 3 to 11% with a greater incidence in female population(8.7% of men and 9.3% of women) ,....
Methods and materials
The study population consists of participants (male or female aged ≥40 years)with moderate-severe pain attributable to hip OA (mild- high grade of OA) and supported by Radiographic or MRI evidence of hip OA,
with symptom duration at least 6 weeks not responding to oral therapy [Fig.1]. Exclusion criteria were: hip pain due to other disorders (e.g.
rheumatoid arthritis);current or previous infection of the affected hip; anticoagulant therapy; any other contraindications to the use of our...
The mean pre-treatment VAS value was 7,5 ± 0,86 median 8 [5-10]. Assuming that all patients reported an improvement in symptoms immediately after the infiltrative treatment,
our interest was to evaluate the results at a greater temporal distance; our meantime follow-up was 2 ± 1,44 years. According to our experience,
mean VAS reduction was 4,13 ±1,37 (VAS improvement 46%) as well as an improvement of the functional status (HHS improvement 42%). Pain-free time-period was progressively reduced...
We observeda significant improvement of the assessed clinical domains in the majority of the treated patients. According to our experience,
patients treated with HA infiltration at the hip level find benefit from the treatment both at the first short-term follow-up but also at the long-term follow-up performed on average after 2 ± 1,44 years. The advancing age and degenerative hip pathology make infiltrative therapies less and less effective; in fact,
patients who underwent infiltrative...
“The effectiveness of intra-articular injections of Hyalubrix� combined with exercise therapy in the treatment of hip osteoarthritis,” Clin.
Bone Metab. ,
2017.  M.
“Short-Term Outcomes of Treatment of Hip Osteoarthritis With 4 Bone Marrow Concentrate Injections: A Case Series,” Clin.
Insights Case Reports ,
2018.  F.